Company-wide revenue
Reported revenue in 2021 ¥3.29T Reported revenue in 2025 ¥3.82T
- growth amount
- +¥526.43B
- growth annualized
- +3.8%
- growth total
- +16.0%
Japanese company profile · 7459
In its FY2025 public filing, MEDIPAL HOLDINGS CORPORATION reports Wholesale of Prescription Medicines and Related Products, Wholesale of cosmetics, household goods, and general pharmaceuticals, Wholesale of animal medicines and food processing raw materials. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社メディパルホールディングス
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
MEDIPAL HOLDINGS CORPORATION's largest reported business by revenue in FY2025 was Wholesale of Prescription Medicines and Related Products.
The business with the highest reported segment profit in FY2025 was Wholesale of cosmetics, household goods, and general pharmaceuticals.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Wholesale of Prescription Medicines and Related Products | ¥2.47T ↗ | 64.6% | ¥24.29B ↗ |
| Wholesale of cosmetics, household goods, and general pharmaceuticals | ¥1.24T ↗ | 32.4% | ¥26.43B ↗ |
| Wholesale of animal medicines and food processing raw materials | ¥117.33B ↗ | 3.1% | ¥2.33B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2021 ¥3.29T Reported revenue in 2025 ¥3.82T
Reported revenue in 2021 ¥2.18T Reported revenue in 2025 ¥2.47T
Reported revenue in 2021 ¥1.05T Reported revenue in 2025 ¥1.24T
Reported revenue in 2021 ¥71.86B Reported revenue in 2025 ¥117.33B
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YI1C
View original filing ↗Ask about this company
The source document may be in Japanese.